Gene · 5376
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells. | Brain | 2024 | 38743588 | PubTator, text mining | PubMed |
| What is the role of out of programme clinical fellowships in the era of Shape of Training? A single-centre cohort study. | BMJ Open Gastroenterol | 2024 | 38688716 | PubTator, text mining | PubMed |
| Recurrent Ipsilateral C5 Nerve Palsy Associated With Hereditary Neuropathy With Liability to Pressure Palsy. | Cureus | 2024 | 38601388 | PubTator, text mining | PubMed |
| A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A. | J Peripher Nerv Syst | 2024 | 38581130 | PubTator, text mining | PubMed |
| [Genetic analysis of a Chinese pedigree affected with atypical Charcot-Marie-Tooth disease type 1A due to duplication of PMP22 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 38565510 | PubTator, text mining | PubMed |
| Diagnostic Neuromuscular Ultrasound to Confirm Clinical Significance of a Genetic Variant for Charcot-Marie-Tooth Type 4C: A Case Report. | Am J Phys Med Rehabil | 2024 | 38547040 | PubTator, text mining | PubMed |
| Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication. | Stem Cell Res | 2024 | 38537501 | PubTator, text mining | PubMed |
| Testing SIPA1L2 as a modifier of CMT1A using mouse models. | J Neuropathol Exp Neurol | 2024 | 38472136 | PubTator, text mining | PubMed |
| Early Onset Inherited Peripheral Neuropathies: The Experience of a Specialized Referral Center for Genetic Diagnosis Achievement. | Pediatr Neurol | 2024 | 38428336 | PubTator, text mining | PubMed |
| Intermediate conduction velocity in two cases of Charcot-Marie-Tooth disease type 1A. | Eur J Neurol | 2024 | 38409938 | PubTator, text mining | PubMed |
| Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn's disease. | JCI Insight | 2024 | 38385744 | PubTator, text mining | PubMed |
| Demyelination and Na+ Channel Redistribution Underlie Auditory and Vestibular Dysfunction in PMP22-Null Mice. | eNeuro | 2024 | 38378628 | PubTator, text mining | PubMed |
| A Framework for Evaluating Local Adaptive Capacity to Health Impacts of Climate Change: Use of Kenya's County-Level Integrated Development Plans. | Ann Glob Health | 2024 | 38370864 | PubTator, text mining | PubMed |
| Pan-cancer proteogenomics characterization of tumor immunity. | Cell | 2024 | 38359819 | PubTator, text mining | PubMed |
| Roussy-Lévy Syndrome: Pes Cavus, Tendon Areflexia, Amyotrophy, Gait Ataxia, and Upper Limb Tremor in a Patient with CMT Neuropathy. | Tremor Other Hyperkinet Mov (N Y) | 2024 | 38344215 | PubTator, text mining | PubMed |
| Exploration of neuron heterogeneity in human heart failure with dilated cardiomyopathy through single-cell RNA sequencing analysis. | BMC Cardiovasc Disord | 2024 | 38310240 | PubTator, text mining | PubMed |
| Enhancing the Reliability of PMP22 Copy Number Variation Detection with an Inherited Peripheral Neuropathy Panel. | J Mol Diagn | 2024 | 38301867 | PubTator, text mining | PubMed |
| A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy. | Mayo Clin Proc Innov Qual Outcomes | 2024 | 38283096 | PubTator, text mining | PubMed |
| The unusual gene architecture of polyubiquitin is created by dual-specific splice sites. | Genome Biol | 2024 | 38268025 | PubTator, text mining | PubMed |
| Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis. | Heliyon | 2024 | 38261862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5376/papers?page=8